{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:10:59Z","timestamp":1780661459174,"version":"3.54.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01507-w","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:40:33Z","timestamp":1780659633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics, Treatments, and Outcomes of Early-Onset Appendiceal Cancer: NCDB Analysis"],"prefix":"10.1007","volume":"57","author":[{"given":"Sameh Hany","family":"Emile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjelli","family":"Wignakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Garoufalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Wexner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"1507_CR1","doi-asserted-by":"publisher","first-page":"e0294153","DOI":"10.1371\/journal.pone.0294153","volume":"18","author":"D Wang","year":"2023","unstructured":"Wang D, Ge H, Lu Y, Gong X. Incidence trends and survival analysis of appendiceal tumors in the United States: Primarily changes in appendiceal neuroendocrine tumors. PLoS ONE. 2023;18:e0294153. https:\/\/doi.org\/10.1371\/journal.pone.0294153.","journal-title":"PLoS ONE"},{"key":"1507_CR2","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1148\/rg.233025134","volume":"23","author":"PJ Pickhardt","year":"2003","unstructured":"Pickhardt PJ, Levy AD, Rohrmann CA, Kende AI. Primary neoplasms of the appendix: radiologic spectrum of disease with pathologic correlation. Radiographics. 2003;23:645\u201362.","journal-title":"Radiographics"},{"key":"1507_CR3","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s00384-013-1714-9","volume":"28","author":"MG van den Heuvel","year":"2013","unstructured":"van den Heuvel MG, Lemmens VE, Verhoeven RH, de Hingh IH. The incidence of mucinous appendiceal malignancies: a population-based study. Int J Colorectal Dis. 2013;28:1307\u201310.","journal-title":"Int J Colorectal Dis"},{"key":"1507_CR4","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1002\/cncr.10589","volume":"94","author":"ME McCusker","year":"2002","unstructured":"McCusker ME, Cot\u00e9 TR, Clegg LX, Sobin LH. Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973\u20131998. Cancer. 2002;94:3307\u201312.","journal-title":"Cancer"},{"key":"1507_CR5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ejso.2007.04.002","volume":"34","author":"RM Smeenk","year":"2008","unstructured":"Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA. Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol. 2008;34:196\u2013201.","journal-title":"Eur J Surg Oncol"},{"key":"1507_CR6","unstructured":"Osueni A, Chowdhury YS, Appendix Cancer. [Updated 2023 Aug 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK555943. Accessed on May 28, 2025."},{"key":"1507_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/COC.0000000000000210","volume":"40","author":"WL Shaib","year":"2017","unstructured":"Shaib WL, Goodman M, Chen Z, et al. Incidence and Survival of Appendiceal Mucinous Neoplasms: A SEER Analysis. Am J Clin Oncol. 2017;40:569\u201373.","journal-title":"Am J Clin Oncol"},{"key":"1507_CR8","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.3390\/cancers15112979","volume":"15","author":"AM Zaborowski","year":"2023","unstructured":"Zaborowski AM, REACCT Collaborative. Colorectal Cancer in the Young: Research in Early Age Colorectal Cancer Trends (REACCT) Collaborative. Cancers (Basel). 2023;15:2979. https:\/\/doi.org\/10.3390\/cancers15112979.","journal-title":"Cancers (Basel)"},{"key":"1507_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4251\/wjgo.v14.i1.230","volume":"14","author":"CW Wu","year":"2022","unstructured":"Wu CW, Lui RN. Early-onset colorectal cancer: Current insights and future directions. World J Gastrointest Oncol. 2022;14:230\u201341. https:\/\/doi.org\/10.4251\/wjgo.v14.i1.230.","journal-title":"World J Gastrointest Oncol"},{"key":"1507_CR10","doi-asserted-by":"publisher","first-page":"e000049","DOI":"10.1136\/bmjonc-2023-000049","volume":"2","author":"J Zhao","year":"2023","unstructured":"Zhao J, Xu L, Sun J, et al. Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019. BMJ Oncol. 2023;2:e000049.","journal-title":"BMJ Oncol"},{"key":"1507_CR11","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.3390\/cancers14164021","volume":"14","author":"AC Hamilton","year":"2022","unstructured":"Hamilton AC, Donnelly DW, Fitzpatrick D, Coleman HG. Early-Onset Cancers in Adults: A Review of Epidemiology, Supportive Care Needs and Future Research Priorities. Cancers (Basel). 2022;14:4021. https:\/\/doi.org\/10.3390\/cancers14164021.","journal-title":"Cancers (Basel)"},{"key":"1507_CR12","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1158\/1055-9965.EPI-20-1505","volume":"30","author":"T Gibbs","year":"2021","unstructured":"Gibbs T, Washington MK, Eng C, Idrees K, Davis J, Holowatyj AN. Histologic and Racial\/Ethnic Patterns of Appendiceal Cancer among Young Patients. Cancer Epidemiol Biomarkers Prev. 2021;30:1149\u201355. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-1505.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1507_CR13","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1053\/j.gastro.2020.06.011","volume":"159","author":"AN Holowatyj","year":"2020","unstructured":"Holowatyj AN, Washington KM, Salaria SN, Lieu CH, Idrees K, Eng C. Early-Onset Appendiceal Cancer Survival by Race or Ethnicity in the United States. Gastroenterology. 2020;159:1605\u20138. https:\/\/doi.org\/10.1053\/j.gastro.2020.06.011.","journal-title":"Gastroenterology"},{"key":"1507_CR14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","volume":"15","author":"KY Bilimoria","year":"2008","unstructured":"Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15:683\u201390. https:\/\/doi.org\/10.1245\/s10434-007-9747-3.","journal-title":"Ann Surg Oncol"},{"key":"1507_CR15","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.3390\/cancers15123202","volume":"15","author":"F Ullah","year":"2023","unstructured":"Ullah F, Pillai AB, Omar N, Dima D, Harichand S. Early-Onset Colorectal Cancer: Current Insights. Cancers (Basel). 2023;15:3202. https:\/\/doi.org\/10.3390\/cancers15123202.","journal-title":"Cancers (Basel)"},{"key":"1507_CR16","doi-asserted-by":"publisher","first-page":"e2028644","DOI":"10.1001\/jamanetworkopen.2020.28644","volume":"3","author":"AN Holowatyj","year":"2020","unstructured":"Holowatyj AN, Eng C, Wen W, Idrees K, Guo X. Spectrum of Somatic Cancer Gene Variations Among Adults With Appendiceal Cancer by Age at Disease Onset. JAMA Netw Open. 2020;3:e2028644. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.28644.","journal-title":"JAMA Netw Open"},{"key":"1507_CR17","doi-asserted-by":"publisher","unstructured":"Wang D, Ge H, Lu Y, Gong X (2023) Incidence trends and survival analysis of appendiceal tumors in the United States: Primarily changes in appendiceal neuroendocrine tumors. PLoS One 18:e0294153. https:\/\/doi.org\/10.1371\/journal.pone.0294153.","DOI":"10.1371\/journal.pone.0294153"},{"key":"1507_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/cancers15010295","volume":"15","author":"A Mohamed","year":"2022","unstructured":"Mohamed A, Wu S, Hamid M, et al. Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines. Cancers (Basel). 2022;15:295. https:\/\/doi.org\/10.3390\/cancers15010295.","journal-title":"Cancers (Basel)"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01507-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01507-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01507-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:40:36Z","timestamp":1780659636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01507-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1507"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01507-w","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Steven Wexner is a consultant for ActivSurgical, Arthrex, Baxter, Becton, Dickinson and Co., Evologics, Glaxo Smith Kline, Intuitive Surgical, New Med Tek Devices, Polypid, Ostomy Secure, Seikagaku, and Takeda, receives stock options for consulting from Polypid and Ostomy Secure, and receives royalties from Intuitive Surgical, Karl Storz Endoscopy America Inc., and Unique Surgical Solutions, LLC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"134"}}